These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35437863)

  • 1. Coronary microvascular dysfunction is common in patients hospitalized with COVID-19 infection.
    Çalışkan M; Baycan ÖF; Çelik FB; Güvenç TS; Atıcı A; Çağ Y; Konal O; İrgi T; Bilgili ÜZ; Ağırbaşlı MA
    Microcirculation; 2022 Jul; 29(4-5):e12757. PubMed ID: 35437863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary Microvascular Dysfunction Restored After Surgery in Inflammatory Bowel Disease: A Prospective Observational Study.
    Kakuta K; Dohi K; Yamamoto T; Fujimoto N; Shimoyama T; Umegae S; Ito M
    J Am Heart Assoc; 2021 May; 10(9):e019125. PubMed ID: 33899514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary microvascular dysfunction and myocardial contractile reserve in women with angina and no obstructive coronary artery disease.
    Michelsen MM; Pena A; Mygind ND; Bech J; Gustafsson I; Kastrup J; Hansen HS; Høst N; Hansen PR; Prescott E
    Echocardiography; 2018 Feb; 35(2):196-203. PubMed ID: 29222822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights to the potential mechanisms driving coronary flow reserve impairment in Cushing's syndrome: A pilot noninvasive study by transthoracic Doppler echocardiography.
    Tona F; Boscaro M; Barbot M; Maritan L; Famoso G; Dal Lin C; Montisci R; Fallo F; Iliceto S; Scaroni C
    Microvasc Res; 2020 Mar; 128():103940. PubMed ID: 31678361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary microvascular dysfunction is associated with degree of anaemia in end-stage renal disease.
    Radhakrishnan A; Pickup LC; Price AM; Law JP; McGee KC; Fabritz L; Senior R; Steeds RP; Ferro CJ; Townend JN
    BMC Cardiovasc Disord; 2021 Apr; 21(1):211. PubMed ID: 33902440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial CT perfusion compared with transthoracic Doppler echocardiography in evaluation of the coronary microvascular function: An iPOWER substudy.
    Bechsgaard DF; Hove JD; Michelsen MM; Mygind ND; Pena A; Hansen PR; Hansen HS; Kastrup J; Høst N; Gustafsson I; Prescott E
    Clin Physiol Funct Imaging; 2021 Jan; 41(1):85-94. PubMed ID: 33030280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological Stratification of Patients With Angina Due to Coronary Microvascular Dysfunction.
    Rahman H; Demir OM; Khan F; Ryan M; Ellis H; Mills MT; Chiribiri A; Webb A; Perera D
    J Am Coll Cardiol; 2020 May; 75(20):2538-2549. PubMed ID: 32439003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral Reactive Hyperemia Index and Coronary Microvascular Function in Women With no Obstructive CAD: The iPOWER Study.
    Michelsen MM; Mygind ND; Pena A; Aziz A; Frestad D; Høst N; Prescott E;
    JACC Cardiovasc Imaging; 2016 Apr; 9(4):411-7. PubMed ID: 27056160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired coronary flow velocity reserve is associated with cardiovascular risk factors but not with angina symptoms.
    Bove KB; Michelsen MM; Schroder J; Suhrs HE; Bechsgaard DF; Mygind ND; Aziz A; Kastrup J; Gustafsson I; Prescott E
    Open Heart; 2021 Jan; 8(1):. PubMed ID: 33462108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation, non-endothelial dependent coronary microvascular function and diastolic function-Are they linked?
    Suhrs HE; Schroder J; Bové KB; Mygind ND; Frestad D; Michelsen MM; Lange T; Gustafsson I; Kastrup J; Prescott E
    PLoS One; 2020; 15(7):e0236035. PubMed ID: 32673354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study.
    Mygind ND; Michelsen MM; Pena A; Qayyum AA; Frestad D; Christensen TE; Ghotbi AA; Dose N; Faber R; Vejlstrup N; Hasbak P; Kjaer A; Prescott E; Kastrup J;
    J Cardiovasc Magn Reson; 2016 Nov; 18(1):76. PubMed ID: 27809867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral Endothelial Function and Coronary Flow Velocity Reserve Are Not Associated in Women with Angina and No Obstructive Coronary Artery Disease: The iPOWER Study.
    Flintholm Raft K; Frestad D; Michelsen MM; Suhrs HE; Rask AB; Nilsson M; Hermann TS; Prescott E
    J Vasc Res; 2017; 54(5):309-319. PubMed ID: 28942444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary flow velocity reserve predicts adverse prognosis in women with angina and no obstructive coronary artery disease: results from the iPOWER study.
    Schroder J; Michelsen MM; Mygind ND; Suhrs HE; Bove KB; Bechsgaard DF; Aziz A; Gustafsson I; Kastrup J; Prescott E
    Eur Heart J; 2021 Jan; 42(3):228-239. PubMed ID: 33477168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiparametric analysis of coronary flow in psoriasis using a coronary flow reserve companion.
    Tona F; Osto E; Kerkhof PLM; Montisci R; Famoso G; Lorenzoni G; De Michieli L; Cecere A; Zanetti I; Civieri G; Iliceto S; Piaserico S
    Eur J Clin Invest; 2022 Apr; 52(4):e13711. PubMed ID: 34780064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary microvascular dysfunction is associated with cardiac time intervals in women with angina and no obstructive coronary artery disease: An iPOWER substudy.
    Pena A; Michelsen MM; Mygind ND; Gustafsson I; Høst N; Bech J; Kastrup J; Hansen HS; Hansen PR; Prescott E
    Echocardiography; 2019 Jun; 36(6):1110-1117. PubMed ID: 31012159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cardiovascular magnetic resonance imaging-based pilot study to assess coronary microvascular disease in COVID-19 patients.
    Drakos S; Chatzantonis G; Bietenbeck M; Evers G; Schulze AB; Mohr M; Fonfara H; Meier C; Yilmaz A
    Sci Rep; 2021 Aug; 11(1):15667. PubMed ID: 34341436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceleration time of systolic coronary flow velocity to diagnose coronary stenosis in patients with microvascular dysfunction.
    Takemoto K; Hirata K; Wada N; Shiono Y; Komukai K; Tanimoto T; Ino Y; Kitabata H; Takarada S; Nakamura N; Kubo T; Tanaka A; Imanishi T; Akasaka T
    J Am Soc Echocardiogr; 2014 Feb; 27(2):200-7. PubMed ID: 24345631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary Flow Velocity Reserve Reduction Is Associated with Cardiovascular, Cancer, and Noncancer, Noncardiovascular Mortality.
    Gaibazzi N; Picano E; Suma S; Garibaldi S; Porter TR; Botti A; Tuttolomondo D; Tedeschi A; Lorenzoni V
    J Am Soc Echocardiogr; 2020 May; 33(5):594-603. PubMed ID: 32173203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary flow velocity reserve and inflammatory markers in living kidney donors.
    Radhakrishnan A; Price AM; Pickup LC; Law JP; McGee KC; Fabritz L; Senior R; Steeds RP; Ferro CJ; Townend JN
    Int J Cardiol; 2020 Dec; 320():141-147. PubMed ID: 32805328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Relevance of Ischemia with Nonobstructive Coronary Arteries According to Coronary Microvascular Dysfunction.
    Lee SH; Shin D; Lee JM; van de Hoef TP; Hong D; Choi KH; Hwang D; Boerhout CKM; de Waard GA; Jung JH; Mejia-Renteria H; Hoshino M; Echavarria-Pinto M; Meuwissen M; Matsuo H; Madera-Cambero M; Eftekhari A; Effat MA; Murai T; Marques K; Doh JH; Christiansen EH; Banerjee R; Kim HK; Nam CW; Niccoli G; Nakayama M; Tanaka N; Shin ES; Chamuleau SAJ; van Royen N; Knaapen P; Koo BK; Kakuta T; Escaned J; Piek JJ;
    J Am Heart Assoc; 2022 May; 11(9):e025171. PubMed ID: 35475358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.